News & Events
21 December 2020
Recruitment restarted
We are very happy to announce that patient recruitment for the EFFECT trial is progressing! Most sites were able to take measures to deal with the COVID-19 related restrictions and recruitment has been restarted. Off course, challenges remain but we are grateful that we can offer a place to most women now who are willing to join.
13 March 2020
COVID-19: On-hold status recruitment
Due to the COVID-19 pandemic, the patient recruitment for the EFFECT trial has been put on hold. All patients who were already included stopped exercising at a physiotherapy centre and will continue when they are allowed to. In the meantime, patients will perform home-based exercise.
5 March 2020 - 6 March 2020
3rd Consortium Meeting in Gdańsk, Poland
This time, the consortium meeting took place at the Medical University of Gdańsk in Poland.

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.